EQUITY RESEARCH MEMO
Amplifi Vascular
Generated 5/9/2026
Executive Summary
Conviction (model self-assessment)65/100
Amplifi Vascular is a private medical device company based in San Jose, CA, dedicated to transforming vascular access outcomes for patients with end-stage renal disease. The company's flagship product, the Amplifi Vein Dilation System, is a proprietary blood pump technology designed to enlarge veins, thereby improving eligibility for arteriovenous fistula (AVF) surgery, accelerating AVF maturation, reducing failure rates, and extending primary patency. By addressing key limitations in current AVF creation and maintenance, Amplifi's solution aims to enhance the standard of care for hemodialysis patients, who often face complications from inadequate vascular access.
Upcoming Catalysts (preview)
- Q3 2026FDA 510(k) Clearance for Vein Dilation System70% success
- Q2 2026Publication of Initial Clinical Study Results60% success
- Q4 2026Strategic Partnership or Distribution Agreement50% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)